Influence of ischemia/reperfusion and modulation of PI3K/Akt kinase pathway on matrix metalloproteinase-2 in rat hearts

General Physiology and Biophysics

Volumn 29, Issue 1, 2010, Pages 31-40

  Špániková, Anna ^a,b   Ivanová, Monika ^a   Matejíková, Jana ^a   Ravingerová, Táňa ^a   Barančík, Miroslav ^a  

^a Institute for Heart Research   (Slovakia)

^b INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

Author keywords

Akt kinase; Heart; Ischemia; Matrix metalloproteinases

Indexed keywords

GELATINASE A; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; IMMUNOBLOTTING; ISCHEMIC PRECONDITIONING; ISOLATED HEART; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; REPERFUSION; SIGNAL TRANSDUCTION; ZYMOGRAPHY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; HEART; MALE; MATRIX METALLOPROTEINASE 2; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; ONCOGENE PROTEIN V-AKT; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

RATTUS;

EID: 77952058772     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: 10.4149/gpb_2010_01_31     Document Type: Article

References (33)

1. Bae I. H., Park M. J., Yoon S. H., Kang S. W., Lee S. S., Choi K. M., Um H. D. (2006): Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1. Cancer Res. 66, 4991-4995; doi:10.1158/0008-5472.CAN-05-4254
2. Birkedal-Hansen H. (1995): Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell. Biol. 7, 728-735; doi:10.1016/0955-0674(95)80116-80122
3. Bolli R., Marban E. (1999): Molecular and cellular mechanisms of myocardial stunning. Physiol. Rev. 79, 609-634
4. Bradford M. (1976): A rapid and sensitive method for the quantitation of microgram quanties of protein utilizing the principle of protein-dye-binding. Anal. Biochem. 72, 248-254; doi:10.1016/0003-2697(76)90527-3
5. Hausenloy D. J., Mocanu M. M., Yellon D. M. (2004): Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning. Cardiovasc. Res. 63, 305-312; doi:10.1016/j.cardiores.2004.04. 011
6. Cheung P. Y., Sawicki G., Wozniak M., Wang W., Radomski M. W., Schulz R. (2000): Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101, 1833-1839 (Pubitemid 30213106)
7. Csonka C., Csont T., Onody A., Ferdinandy P. (2001): Preconditioning decreases ischemia/reperfusion-induced peroxynitrite formation. Biochem. Biophys. Res. Commun. 285, 1217-1219; doi:10.1006/bbrc.2001.5308
8. Fert-Bober J., Leon H., Sawicka J., Basran R. S., Devon R. M., Schulz R., Sawicki G. (2008): Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion. Basic Res. Cardiol. 103, 431-443; doi:10.1007/s00395-008- 0727-y
9. Hausenloy D. J., Mocanu M. M., Yellon D. M. (2004): Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning. Cardiovasc. Res. 63, 305-312; doi:10.1016/j.cardiores.2004.04. 011
10. Kloner R. A., Jennings R. B. (2001): Consequences of brief ischemia: stunning, preconditioning, and their clinical implications. Circulation 104, 2981-2989; doi:10.1161/hc4801.100038
11. Kukreja R. C., Salloum F., Das A., Ockaili R., Yin C., Bremer Y. A., Fisher P. W., Wittkamp M., Hawkins J., Chou E., Kukreja A. K., Wang X., Marwaha V. R., Xi L. (2005): Pharmacological preconditioning with sildenafil: basic mechanisms and clinical implications. Vascul. Pharmacol. 42, 219-232; doi:10.1016/j.vph.2005.02.010
12. Kurata H., Thant A. A., Matsuo S., Senga T., Okazaki K., Hotta N., Hamaguchi M. (2000): Constitutive activation of MAP kinase kinase (MEKl) is critical and sufficient for the activation of MMP-2. Exp. Cell. Res. 254, 180-188; doi:10.1006/excr.1999.4738
13. Lalu M. M., Csonka C., Giricz Z., Csont T., Schulz R., Ferdinandy P. (2002): Preconditioning decreases ischemia/reperfusion-induced release and activation of matrix metalloproteinase-2. Biochem. Biophys. Res. Commun. 296, 937-941; doi:10.1016/S0006-291X(02)02019-3
14. Lee S. J., Bae S. S., Kim K. H., Lee W. S., Rhim B. Y., Hong K. W., Kim C. D. (2007): High glucose enhances MMP-2 production in adventitial fibroblasts via Akt1-dependent NF-κB pathway. FEBS Lett. 581, 4189-4194; doi:10.1016/j.febslet.2007.07.058
15. Murry C. E., Jennings R. B., Reimer K. A. (1986): Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136
16. Okamoto T., Akaike T., Nagano T., Miyajima S., Suga M., Ando M., Ichimori K., Maeda H. (1997): Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. Arch. Biochem. Biophys. 342, 261-274; doi:10.1006/abbi.1997.0127
17. Okamoto T., Akaike T., Sawa T., Miyamoto Y., van der Vliet A., Maeda H. (2001): Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J. Biol. Chem. 276, 29596-29602; doi:10.1074/jbc.M102417200
18. Peterson J. T., Hallak H., Johnson L., Li H., O'Brien P. M., Sliskovic D. R., Bocan T. M., Coker M. L., Etoh T., Spinale F. G. (2001): Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation 103, 2303-2309
19. Ravingerová T., Matejíková J., Neckář J., Andelová E., Kolář F. (2007): Differential role of PI3K/Akt pathway in the infarct size limitation and antiarrhythmic protection in the rat heart. Mol. Cell. Biochem. 297, 111-120; doi:10.1007/s11010-006-9335-z
20. Sawicki G., Leon H., Sawicka J., Sariahmetoglu M., Schulze C. J., Scott P. G., Schulz R. (2005): Degradation of myosin light chain in isolated.rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 112, 544-552; doi:10.1161/ CIRCULATIONAHA.104.531616
21. Schonbeck U., Mach F., Sukhova G. K., Murphy C., Bonnefoy J. Y., Fabunmi R. P., Libby P. (1997): Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes. Circ. Res. 81, 448-454
22. Strnisková M., Ravingerová T., Neckář J., Kolář F., Pastoreková S., Barančík M. (2006): Changes in the expression and/or activation of regulatory proteins in rat hearts adapted to chronic hypoxia. Gen. Physiol. Biophys. 25, 25-41
23. Strohm C., Barančík M., Bruhl M. L., Kilian S. A., Schaper W. (2000): Inhibition of the ER-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium. J. Cardiovasc. Pharmacol. 36, 218-229; doi:10.1097/00005344-200008000-00012
24. Sung M. M., Schulz C. G., Wang W., Sawicki G., Bautista-Lopez N. L., Schulz R. (2007): Matrix metalloproteinase-2 degrades the cytoskeletal protein a-actinin in peroxynitrite mediated myocardial injury. J. Mol. Cell. Cardiol. 43, 429-436; doi:10.1016/j.yjmcc.2007.07.055
25. Šimončíková P., Ravingerová T., Andelová E., Tribulová N., Barančík M. (2007): Changes in rat myocardium associated with modulation of ischemic tolerance by diazoxide. Gen. Physiol. Biophys. 26, 75-85
26. Špániková A., Šimončí ková P., Ravingerová T., Pecháňová T., Barančík M. (2008): The effect of chronic nitric oxide synthases inhibition on regulatory proteins in rat hearts. Mol. Cell. Biochem. 312, 113-120; doi:10.1007/s11010-008-9726-4
27. Tong H., Chen W., Steenberg C., Murphy E. (2000): Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ. Res. 87, 309-315
28. Uchiyama T., Engelman R. M., Maulik N., Das D. K. (2004): Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning. Circulation 109, 3042-3049; doi:10.1161/01.CIR.0000130647. 29030.90
29. Viappiani S., Sawicki G., Crawford B., Leon H., Schulz R. (2006): Peroxynitrate modulates 72 kDa matrix metalloproteinase-2 activity through s-nitrosylation of critical cysteines. J. Mol. Cell. Cardiol. 40, 907; doi:10.1016/j.yjmcc.2006.03.405
30. Viappiani S., Nicolescu A. C., Holt A., Sawicki G., Crawford B. D., Leon H., van Mulligen T., Schulz R. (2009): Activation and modulation of 72 kDa matrix metalloproteinase-2 by peroxynitrite and glutathione. Biochem. Pharmac. 77, 826-834; doi:10.1016/j.bcp.2008.11.004
31. Wang W., Sawicki G., Schulz R. (2002a): Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc. Res. 53, 165-174; doi:10.1016/S0008-6363(01)00445-X
32. Wang W., Schulze C. J., Suarez-Pinzon W. L., Dyck J. R., Sawicki G., Schulz R. (2002b): Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106, 1543-1549; doi:10.1161/01.CIR.0000028818.33488.7B
33. Yasmin W., Strynadka K. D., Schulz R. (1997): Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc. Res. 33, 422-432; doi:10.1016/S0008-6363(96)00254-4